MA29565B1 - Combinaison de composes de pyrimidylaminobenzamide et imatinib permettant de traiter ou de prevenir les maladies proliferatives - Google Patents
Combinaison de composes de pyrimidylaminobenzamide et imatinib permettant de traiter ou de prevenir les maladies proliferativesInfo
- Publication number
- MA29565B1 MA29565B1 MA30509A MA30509A MA29565B1 MA 29565 B1 MA29565 B1 MA 29565B1 MA 30509 A MA30509 A MA 30509A MA 30509 A MA30509 A MA 30509A MA 29565 B1 MA29565 B1 MA 29565B1
- Authority
- MA
- Morocco
- Prior art keywords
- combination
- treating
- pyrimidylaminobenzamide
- proliferative diseases
- preventing proliferative
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical class C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 title abstract 2
- 230000002062 proliferating effect Effects 0.000 title abstract 2
- 239000005517 L01XE01 - Imatinib Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 abstract 1
- 229960002411 imatinib Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68775805P | 2005-06-03 | 2005-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA29565B1 true MA29565B1 (fr) | 2008-06-02 |
Family
ID=36968749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA30509A MA29565B1 (fr) | 2005-06-03 | 2007-12-26 | Combinaison de composes de pyrimidylaminobenzamide et imatinib permettant de traiter ou de prevenir les maladies proliferatives |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US7767688B2 (enExample) |
| EP (1) | EP1893213B1 (enExample) |
| JP (2) | JP5281887B2 (enExample) |
| KR (1) | KR101276425B1 (enExample) |
| CN (1) | CN101180060B (enExample) |
| AT (1) | ATE457727T1 (enExample) |
| AU (1) | AU2006255559B2 (enExample) |
| BR (1) | BRPI0611506A2 (enExample) |
| CA (1) | CA2608814C (enExample) |
| CY (1) | CY1110027T1 (enExample) |
| DE (1) | DE602006012313D1 (enExample) |
| DK (1) | DK1893213T3 (enExample) |
| ES (1) | ES2339593T3 (enExample) |
| HR (1) | HRP20100265T1 (enExample) |
| IL (1) | IL187408A0 (enExample) |
| MA (1) | MA29565B1 (enExample) |
| MX (1) | MX2007015159A (enExample) |
| NO (1) | NO20080037L (enExample) |
| NZ (1) | NZ563446A (enExample) |
| PL (1) | PL1893213T3 (enExample) |
| PT (1) | PT1893213E (enExample) |
| RU (1) | RU2430727C2 (enExample) |
| SI (1) | SI1893213T1 (enExample) |
| TN (1) | TNSN07453A1 (enExample) |
| WO (1) | WO2006132930A1 (enExample) |
| ZA (1) | ZA200709473B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE457727T1 (de) * | 2005-06-03 | 2010-03-15 | Novartis Ag | Kombination aus pyrimidylaminobenzamid- verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen |
| TW201102068A (en) * | 2009-06-02 | 2011-01-16 | Novartis Ag | Treatment of ophthalmologic disorders mediated by alpha-carbonic anhydrase isoforms |
| EP2382976A1 (en) | 2010-04-30 | 2011-11-02 | Hiroshima University | Use of pdgf-r inhibitors for the treatment of lymph node metastasis of gastric cancer |
| CN102719530B (zh) * | 2012-05-07 | 2013-11-06 | 厦门艾德生物医药科技有限公司 | 一种用于检测PDGFRα基因突变的引物、探针及试剂盒 |
| KR101386697B1 (ko) * | 2012-06-18 | 2014-04-18 | 아주대학교산학협력단 | 이매티닙 또는 이의 약학적으로 허용되는 염을 유효성분으로 포함하는 혈관 투과성 관련 질환의 치료 또는 예방용 조성물 |
| US20200206223A1 (en) | 2017-07-26 | 2020-07-02 | Ftf Pharma Private Limited | Liquid dosage forms of imatinib |
| CN116808044A (zh) | 2018-06-15 | 2023-09-29 | 汉达癌症医药责任有限公司 | 激酶抑制剂的盐类及其组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4940418A1 (es) * | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
| GB0215676D0 (en) * | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| AR042042A1 (es) * | 2002-11-15 | 2005-06-08 | Sugen Inc | Administracion combinada de una indolinona con un agente quimioterapeutico para trastornos de proliferacion celular |
| ATE457727T1 (de) * | 2005-06-03 | 2010-03-15 | Novartis Ag | Kombination aus pyrimidylaminobenzamid- verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen |
-
2006
- 2006-06-02 AT AT06760628T patent/ATE457727T1/de active
- 2006-06-02 BR BRPI0611506-3A patent/BRPI0611506A2/pt not_active IP Right Cessation
- 2006-06-02 RU RU2007147957/15A patent/RU2430727C2/ru not_active IP Right Cessation
- 2006-06-02 SI SI200630626T patent/SI1893213T1/sl unknown
- 2006-06-02 EP EP06760628A patent/EP1893213B1/en active Active
- 2006-06-02 NZ NZ563446A patent/NZ563446A/en not_active IP Right Cessation
- 2006-06-02 MX MX2007015159A patent/MX2007015159A/es active IP Right Grant
- 2006-06-02 HR HR20100265T patent/HRP20100265T1/hr unknown
- 2006-06-02 DK DK06760628.5T patent/DK1893213T3/da active
- 2006-06-02 JP JP2008514865A patent/JP5281887B2/ja not_active Expired - Fee Related
- 2006-06-02 KR KR1020077028059A patent/KR101276425B1/ko not_active Expired - Fee Related
- 2006-06-02 WO PCT/US2006/021307 patent/WO2006132930A1/en not_active Ceased
- 2006-06-02 ES ES06760628T patent/ES2339593T3/es active Active
- 2006-06-02 CN CN2006800181195A patent/CN101180060B/zh not_active Expired - Fee Related
- 2006-06-02 PT PT06760628T patent/PT1893213E/pt unknown
- 2006-06-02 DE DE602006012313T patent/DE602006012313D1/de active Active
- 2006-06-02 AU AU2006255559A patent/AU2006255559B2/en not_active Ceased
- 2006-06-02 US US11/915,650 patent/US7767688B2/en not_active Expired - Fee Related
- 2006-06-02 PL PL06760628T patent/PL1893213T3/pl unknown
- 2006-06-02 CA CA2608814A patent/CA2608814C/en not_active Expired - Fee Related
-
2007
- 2007-11-02 ZA ZA200709473A patent/ZA200709473B/xx unknown
- 2007-11-15 IL IL187408A patent/IL187408A0/en not_active IP Right Cessation
- 2007-11-30 TN TNP2007000453A patent/TNSN07453A1/en unknown
- 2007-12-26 MA MA30509A patent/MA29565B1/fr unknown
-
2008
- 2008-01-03 NO NO20080037A patent/NO20080037L/no not_active Application Discontinuation
-
2010
- 2010-04-02 US US12/753,184 patent/US8653093B2/en not_active Expired - Fee Related
- 2010-05-13 CY CY20101100416T patent/CY1110027T1/el unknown
-
2012
- 2012-09-14 JP JP2012203258A patent/JP2013035853A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
| NO2012017I1 (no) | Benzimidazolderivat, fremgangsmåte for fremstilling derav, medikament inneholdende denne forbindelsen samt anvendelse av forbindelsen. | |
| WO2004113275A3 (en) | Methods and compositions for treating amyloid-related diseases | |
| ATE542823T1 (de) | 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
| EP1850658A4 (en) | IMPROVED PROCESS FOR THE TREATMENT OF DEGENERATIVE DISEASES OF RETINA | |
| CL2007001040A1 (es) | Proceso para la preparacion de antagonista de la sustancia p derivado de acil-amino-alquilen-amida. | |
| MX2009012625A (es) | Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21. | |
| WO2007114926A3 (en) | Kinase antagonists | |
| TW200738270A (en) | Method of treating depression using a TNFα antibody | |
| EA200802332A1 (ru) | Пирролопиримидины и их применение | |
| MA29565B1 (fr) | Combinaison de composes de pyrimidylaminobenzamide et imatinib permettant de traiter ou de prevenir les maladies proliferatives | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| WO2007075525A3 (en) | Combination of an iap-inhibitor and a taxane7 | |
| WO2007073497A3 (en) | Calcium channel antagonists | |
| WO2007059230A3 (en) | Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors | |
| NL1028599A1 (nl) | Verbindingen voor de behandeling van ziekten. | |
| WO2007016338A3 (en) | Use of chk2 kinase inhibitors for cancer treatment | |
| WO2006053315A3 (en) | Methods and compositions for treating cellular proliferative diseases | |
| WO2007116029A3 (en) | Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor | |
| WO2007059341A3 (en) | Pyrazolothiazole protein kinase modulators | |
| MA28576B1 (fr) | Procede de preparation de derives n-piperidino-1,5-diphenylpyrazole-3-carboxamide. | |
| WO2007033374A3 (en) | Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| WO2008069976A3 (en) | Compounds and methods for enzyme-mediated tumor imaging and therapy | |
| WO2006060542A3 (en) | Formulations of substituted benzoxazoles |